What happens when a QoE report finds a serious problem mid-deal

You’ve signed the LOI. The deal feels real now—maybe even exciting. Your banker or advisor calls to say the Quality of Earnings report is in, and it flags something unexpected: revenue that doesn’t reconcile, a major customer concentration that wasn’t disclosed, customer acquisition costs higher than represented, or a whole category of expense you missed in the management presentation. The clock is ticking on your financing contingency. Your lender is waiting. And you’re staring at a gap between what you were told and what the auditors actually found.

This scenario happens more than deal teams like to admit. A Quality of Earnings report’s job is to validate (or challenge) the normalized EBITDA number that underpins your offer. When it finds something serious mid-deal, the pressure is immediate: renegotiate, walk, or swallow the gap. Understanding what that discovery actually triggers—legally, financially, and strategically—separates buyers who adapt from those who get stuck.

When a QoE Report Flags a Real Issue

Quality of Earnings reports typically surface problems in three moments: during the planning phase (scoping add-backs and adjustments), during field work (reconciling ledgers, verifying customer data), or during final closeout (discovering something the sellers didn’t volunteer). The third one—mid-deal discovery—is the most disruptive because the LOI is already signed.

Common findings that create real friction include:

• Revenue recognition misstatement: A customer invoice was recorded twice, or revenue from a one-time project was treated as recurring revenue.
• Undisclosed customer losses: A large customer announced they’re leaving, or revenue from one customer is far more concentrated than the owner disclosed.
• Missing or overstated expenses: Owner compensation was lower than claimed, or certain operating expenses were capitalized rather than expensed.
• Working capital trap: The cash conversion cycle is much longer than the management case assumed, tying up more working capital than the deal model anticipated.

The key distinction: is the problem a mistake in the auditor’s calculation, or a mistake in the seller’s numbers? That distinction determines your path forward.

The Negotiation Window and Reps & Warranties

Once a QoE report surfaces a material discrepancy, your first move is always to the LOI’s representation and warranty section. Did the seller represent that the financial statements were prepared in accordance with GAAP? That revenue came from customers listed in a schedule? That no customer represented more than X% of revenue? If the QoE finding contradicts a specific rep, you have contractual ground to either renegotiate the purchase price, demand a hold-back, or claim breach.

The seller’s reaction depends on whether they knew about the issue. If the owner is genuinely surprised by the finding—say, a bookkeeper made an error—they may agree to a price adjustment quickly. If they built the error into their story intentionally or through negligence, the negotiation becomes adversarial fast. Your deal counsel should review the LOI’s indemnification and survival periods before you even bring the issue to the seller’s side.

In most LOI structures for sub-$10M deals, there’s a 12–18 month survival period for reps, meaning you can bring a claim if the problem was either known at signing or should have been discovered in a competent review. A mid-deal QoE finding typically falls squarely in that window.

The Price Adjustment Conversation

A QoE report that reduces normalized EBITDA by, say, $200K on a $2M EBITDA business doesn’t just trim 10% off the valuation. It forces a repricing based on whatever multiple you agreed to. If you negotiated a 6× multiple and EBITDA falls from $2M to $1.8M, your offer should drop by $1.2M—assuming your lender still supports the deal at all.

Many buyers try to negotiate a “split the difference” adjustment, where the gap is shared between buyer and seller. This works when both parties believe the finding is legitimate but the magnitude is debatable. If the seller contests the finding outright—claiming the auditors misinterpreted a business practice or misread a contract—you’re in a dispute-resolution phase that can stall a deal for weeks.

Your leverage in that moment depends on how much of the purchase price is still at risk. If you’ve already transferred deposits, your leverage shrinks. If your financing is conditioned on normalized EBITDA hitting a certain floor and the QoE finding breaches that floor, your lender may release you from the financing commitment, which flips the power back to you.

Financing Contingency and Lender Response

Most acquisition loans include a condition that normalized EBITDA must be within a certain percentage of the pro forma model—typically 90% to 100% of what the buyer modeled at LOI. If a QoE report reduces EBITDA below that threshold, the lender may condition the loan on a price reduction, or they may invoke a reduced-advance clause, lending you less money and requiring more equity.

Lenders have sophisticated QoE reviewers on staff or on retainer. They don’t simply trust the seller’s QoE. They often request their own secondary review, or they’ll wait for the buyer’s QoE and audit it for conservatism. If the lender thinks your auditors were too aggressive in adding back expenses, they may insist those adjustments be reversed, further eroding EBITDA.

The clock on financing contingencies is fixed. If your deadline to close is 45 or 60 days out, a major QoE finding in week three doesn’t leave much time to renegotiate, re-underwrite the loan, and close. This is why many sophisticated buyers order a preliminary QoE or a normalized EBITDA review earlier in the diligence cycle—to surface issues before the LOI is signed.

The Outsourcing Processing Approach to Rapid Discovery

Traditional Quality of Earnings engagements—full audits by big firms or specialized QoE providers—run $15,000 to $50,000 and take 3–6 weeks, depending on deal complexity and seller cooperation. That timeline is built for post-LOI validation on larger deals where the price tag justifies the cost.

For smaller acquisitions, where a mid-deal surprise can kill momentum or blow your contingency window, some buyers use a faster first pass: normalized EBITDA calculated and organized from existing financial records, with a human review step but no site visits or deep audit procedures. Outsourcing Processing operates this way—calculating and organizing normalized earnings data for a buyer’s own review, never as a substitute for the buyer’s own judgment or a licensed CPA’s audited opinion.

The point is speed and cost-effectiveness. If you run a preliminary normalized EBITDA calculation pre-LOI or early post-LOI, you surface major red flags—a missing expense category, undisclosed revenue concentration, or a clearly misstated asset value—before you’re locked into financing timelines. You don’t need a full Quality of Earnings to spot these patterns; you need a structured, human-reviewed calculation of what earnings actually are.

Walking Away vs. Renegotiating

A serious QoE finding is often your legal exit. If the seller misrepresented EBITDA or if a major customer is gone, you likely have grounds to terminate under the LOI’s financing or material adverse change clauses. The question is whether walking away is cheaper than renegotiating.

Calculate the real cost: your sunk diligence expenses (legal, accounting, finder fees if applicable), the time already spent, and the opportunity cost of missing the deal. If renegotiating down by $500K keeps a solid asset on your cap table and you’re confident the adjusted EBITDA is real, you may come out ahead by staying in.

If the finding suggests systemic problems—a business model that doesn’t work at the assumed unit economics, customer churn that’s far worse than claimed, or fraud—then walking is the right move. No amount of repricing fixes a broken business. Your job as a buyer is not to save the deal; it’s to own a profitable one.

Protecting Yourself After Close

If you do renegotiate and close despite a QoE finding, the purchase agreement’s indemnification and escrow mechanics become your main defense. Many sub-$10M deals include a 12–18 month indemnification survival period and a 5–10% purchase price hold-back in escrow. If the seller knew about the issue and didn’t disclose it, that indemnity is your claim mechanism—assuming the seller is solvent and the claim surfaces before the survival period ends.

Make sure your deal documents are precise about what the seller represented and when. A vague rep (“financials are accurate”) is harder to enforce than a specific one (“revenue from [Customer X] for the past two years was $[amount]”). Work with your deal counsel to ensure the QoE finding is documented as a baseline for post-close adjustments or escrow disputes.

Frequently Asked Questions

What happens if the seller disputes the QoE finding?

The seller can request the auditors explain their methodology, or they can hire their own auditors to challenge the finding. If the dispute centers on an interpretation of accounting principles—say, whether a particular item qualifies as an add-back—the two QoEs may differ. Your deal counsel typically coordinates with the seller’s advisors to either align on the finding or agree to a neutral third-party review. If the parties remain deadlocked and the price gap is material, the deal may terminate under the financing or MAC clauses.

Can the QoE finding push my deal below my lender’s minimum EBITDA threshold?

Yes, and that’s a common scenario. If normalized EBITDA falls below the 90% threshold your lender set, the lender may reduce the loan amount, demand a higher equity injection from you, or release you from the financing condition entirely. Your LOI should clarify whether a financing contingency survives a QoE-driven EBITDA reduction, or whether the lender’s decision is final. Many deals renegotiate the purchase price downward to stay within the lender’s advance threshold.

Is a mid-deal QoE finding grounds for termination?

Usually, yes—if the finding contradicts a seller representation in the LOI or if it breaches a financing contingency. Many LOIs include a “financing condition” and a “material adverse change” clause that give the buyer exit rights if normalized EBITDA is materially misstated. Your deal counsel will review the specific language. A minor finding (off-by-a-few-thousand arithmetic errors) may not meet the definition of material; a major one (hidden customer loss, systematic revenue misstatement) typically does.

How much does a full Quality of Earnings report cost, and is a preliminary EBITDA review cheaper?

Full Quality of Earnings engagements by large accounting or M&A firms typically cost $15,000 to $50,000 and take 3–6 weeks. They include field work, customer verification, and auditor attestation—appropriate for deals over $5–10M where the cost-to-deal-value ratio justifies it. Preliminary normalized EBITDA calculations—human-reviewed calculations of add-backs and adjustments without site visits—cost significantly less and run on a faster timeline, making them useful for pre-LOI screening or early diligence on smaller deals.

Should I always order a QoE report before signing the LOI?

Ordering a full QoE pre-LOI is rare because sellers often balk at the cost and intrusion before they’ve committed to the deal. However, a preliminary normalized EBITDA review early in diligence (post-letter of intent but pre-final underwriting) is increasingly common, especially for deals under $10M. It surfaces major issues before your financing clock starts and before you’re locked into contingency deadlines. The decision hinges on deal size, complexity, and how much the seller has already disclosed.

When a Quality of Earnings report surfaces a material issue mid-deal, the outcome depends on three things: the strength of your contractual reps, the lender’s tolerance for variance, and your own willingness to renegotiate or walk. Sophistication here means ordering diligence early enough to surface problems before you’re locked into financing timelines, understanding what your loan agreement actually says about EBITDA variance, and documenting seller representations precisely so you have recourse if the issue was known but undisclosed. The faster you can validate earnings—whether through a full audit or a structured preliminary calculation—the more control you keep over the deal.

This article is educational and does not constitute M&A, investment, or accounting advice — confirm findings with a licensed CPA or M&A advisor before making an offer.

This article is educational and does not constitute M&A, investment, or accounting advice — confirm findings with a licensed CPA or M&A advisor before making an offer.

This is exactly the kind of adjustment IncomeReady keeps organized and ready for your review.